NT5E and metastatic colorectal cancer: In agreement with our findings, another study identified the CD73 gene, NT5E, among a set of 110 candidate genes for which higher expression was associated with decreased likelihood of disease control in metastatic colorectal cancer patients treated with cetuximab monotherapy [39].